CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK

Clinical trials for CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK trials appear

Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Drug trial aims to stop Cancer's return after surgery

Disease control Completed

This study tested whether adding the immunotherapy drug pembrolizumab (MK-3475) to standard surgery could better control advanced head and neck cancer. It involved 67 high-risk patients with stage III or IV cancer that could be surgically removed. Researchers aimed to see if the …

Matched conditions: CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK

Get alerted when new CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK trials appear

Drug trial aims to stop Cancer's return after surgery